ABSTRACT
INTRODUCTION
Diabetes is a metabolic syndrome resulting from hyperglycemia due to decreased indigenous insulin, decreased sensitivity to circulating insulin or both. 1 The estimated world population with diabetes was 366 million in 2011 and is estimated to grow to 552 million in the year 2030. Disease burden is relatively higher in developing countries which comprise around 80% of the world diabetic population. 2 According to WHO estimate, Pakistan had 6.9 million diabetic patients in 2007; a figure which is estimated to become 11.5 million in 2025. 3 Diabetes is a leading cause of preventable blindness in adults aged between 20-75 years. 4 Among the ocular complications of diabetes, diabetic retinopathy is the most frequent and it is responsible for 12% of all new cases of blindness every year. 4, 5 Among patients of type-I and type-II diabetes for more than 20 years, the prevalence of diabetic retinopathy has been reported to be 95% and 60%, respectively. 6 However, the prevalence varies depending upon the population and the age group being studied. [4] [5] [6] Existing research has identified a number of factors attributable for the development of diabetic retinopathy including but not limited to duration of diabetes along with glycemic control, systemic hypertension, hyperlipidemia, obesity and positive family history of diabetes. [7] [8] [9] [10] [11] [12] Prevention and treatment of these attributing factors is as much important as good glycemic control to avoid diabetic retinopathy. 7, 9, 11, 12 Although these risk factors have already been studied in many epidemiological and clinical trials, yet there were considerable differences in the consistency, pattern, and strength of these factors among these studies. As no such local published material could be found, the purpose of the current study was to determine the role of hypertension, hyperlipidemia, smoking and positive family history of diabetes and hypertension in the development of diabetic retinopathy with the hope that the results of this study would help in early identification of high risk diabetic patients allowing timely intervention to reduce the burden of diabetic retinopathy.
METHODS
This was a cohort study conducted at the Department of Chemical Pathology, Armed forces institute of Pathology, Rawalpindi over 2 years period from June 2014 through June 2016. One hundred consecutive diabetic patients reporting at Ophthalmology outdoor were screened on their first visit for presence or absence of diabetic retinopathy. Those patients with no signs of diabetic retinopathy and good glycemic control (HbA1c<6.5%) were registered after taking written informed consent. They were evaluated for hypertension, hyperlipidemia and smoking status. These patients were then followed 6 monthly for 2 years to look for the occurrence of diabetic retinopathy. Patients of ischemic heart disease, chronic liver and kidney diseases were excluded. Same consultant ophthalmologist examined all the patients on every follow-up to eliminate bias.
RESULTS
The mean age of the patients was 50.72±9.29 years and there were 57 (57%) male and 43 (43%) female patients. Majority (82%) of patients had NIDDM. The mean duration of diabetes was 8.31±6.83 years. 11% of the patients were smoker, 37% were hypertensive, 6% had hyperlipidemia, 62% had family history of diabetes and 30% had family history of hypertension. These findings have been summarized in Table-I. At the end of follow-up, 9 (9.0%) patients had diabetic retinopathy. The frequency of diabetic retinopathy increased with increasing age of the patient; 30-40 vs. 41-50 vs. 51-60 years (0.0% vs. 4.5% vs. 14.3%; p=0.099; OR=0.286, 95% CI: 0.03-2.43) however, the difference was statistically insignificant. A comparatively higher frequency of diabetic retinopathy was also seen in patients with IDDM (16.7% vs. 7.3%; p=0.209; OR=0.40, 95% CI: 0.09-1.76) and those with positive family history of diabetes (12.9% vs. 2.6%; p=0.081; OR=5.48, 95% CI: 0.66-45.69) and hypertension (13.3% vs. 7.1%; p=0.322; OR=2.00, 95% CI: 0.50-8.04) yet again, the difference was statistically insignificant. Also no significant difference was noted among male and female genders (8.8% vs. 9.3%; p=0.927; OR=0.938, 95% CI: 0.24-3.72) and 18 Ahmedani et al. also reported variable frequency of smoking (29.5%), family history of diabetes (44.6%) and hypertension (5%) among diabetic patients. 18 Upon final follow-up visit, 9 patients had diabetic retinopathy. This gave an overall frequency of diabetic retinopathy to be 9% among diabetic patients irrespective of diabetes control status in the present study. A similar frequency of diabetic retinopathy (10%) was observed by Shaikh et al. in 2010 among diabetic patients after 10 years of diagnosis while the mean duration of diabetes in our study was 8 years. 19 Wahab et al. in 2008 (15%) 20 and Mahar et al. in 2010 (27.43%) 21 reported relatively higher frequency of DR in local population. Among other populations Cheng et al. in US (11%) 13 , Wong et al. in Australia (11.5%) 22 , Nathan (12.6%) 23 and Agarwal et al. (11.7%) 24 in India and Abdollahi et al. in Iran (13.8%) 25 reported similar frequency of diabetic retinopathy. A much higher frequency of 49.94% was reported by Khanzada et al. in 2011. 26 A possible explanation for this much higher frequency can be the prolonged duration of diabetes among the participants of that study (mean duration=13±4.5 years). 26 This variation can be explained by socioeconomic (availability and affordability of treatment) and educational differences (interest and compliance) in populations and the selection bias among researchers. 20 The frequency of diabetic retinopathy increased with increasing age of the patient (OR=0. 22 The results of the present study are similar to those of previously published studies in this regard among other populations with minor dissimilarities which can be due to population differences. The present study is first of its kind in local population and has identified some very important modifiable risk factors among diabetic patients, timely identification and management of which can help in reducing the development of diabetic retinopathy.
CONCLUSION
Higher patient age (≥50 years), increasing duration of diabetes (≥20 years), insulin dependent diabetes mellitus, hypertension, hyperlipidemia, and positive family history of diabetes and hypertension were found to be associated with increased frequency of diabetic retinopathy. Thus, these factors should be taken into account for control along with glycemic control to decrease the risk of diabetic retinopathy in practice.
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